I. Trinchard-Lugan

The short term secretion pattern of human serum melatonin indicates apulsatile hormone release.

I. Trinchard-Lugan, F. Waldhauser, 1989, The Journal of clinical endocrinology and metabolism.

Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.

A. Munafo, I. Trinchard-Lugan, A. Ythier, 2001, European cytokine network.

Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration

A. Munafo, N. Simonian, I. Trinchard-Lugan, 1999, European journal of neurology.

Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers.

A. Munafo, I. Trinchard-Lugan, H. Porchet, 2002, Reproductive biomedicine online.

Sleep laboratory investigations on hypnotic properties of melatonin

B. Saletu, B. Saletu, I. Trinchard-Lugan, 2005, Psychopharmacology.

Recombinant Human Interferon-β-1a (Rebif®) vs Recombinant Interferon-β-1b (Betaseron®) in Healthy Volunteers

A. Munafo, I. Trinchard-Lugan, M. Macnamee, 1999 .

Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration

A. Munafo, I. Trinchard-Lugan, M. Buraglio, 1999, European journal of neurology.

Initiation of periovulatory events in gonadotrophin-stimulated macaques with varying doses of recombinant human chorionic gonadotrophin.

I. Trinchard-Lugan, D. Wolf, R. Stouffer, 1997, Human reproduction.